Dermabay Skincare

Dermabay is a science-first Indian skincare brand reshaping how we care for Indian skin—by replacing beauty myths with molecular truth. Founded in 2022 in Ludhiana, Punjab, it began with a bold question: Why doesn’t Indian skin have access to clinically effective skincare without the imported price tag or the confusion of home remedies? What started as a lab experiment quickly evolved into one of India’s most promising skincare companies. With zero reliance on trend cycles or white-labeled products, Dermabay has won trust through clinical rigour, transparent practices, and formulation-led innovation. The brand was co-founded by Dr. Divneet Kaur, a pharmaceutical scientist with over 15 years of drug research experience, and Simran Kaur, a healthcare systems strategist with a background in hospital ops and tech transformation. Together, they set out to prove that India can lead its own skincare revolution—merging pharma-grade R&D with direct-to-consumer accessibility. Dermabay’s edge lies in its science-first approach. Every product is built around active molecules, not marketing fluff—think WKPep Erasin peptides, encapsulated retinol, and next-gen antioxidants. No shortcuts: over 40 internal trials precede each launch. Every formula is designed for Indian skin—melanin-rich tones, humid climates, and real-world concerns like hyperpigmentation and barrier repair. Simran leads backend scale—optimizing systems, D2C logistics, and lean customer support. Since launch, Dermabay has earned high repeat rates, built a clinical advisory board, and nurtured a community that values results over trends. At its core, Dermabay stands for: Formulation intelligence. Channel honesty. Consumer trust. It’s not just a brand—it’s a movement. A lab-to-skin revolution, formulated for us, right here in India.